Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: Data from the GISSI-3 study

Circulation

Volumn 96, Issue 12, 1997, Pages 4239-4245

  Zuanetti, Giulio ^a   Latini, Roberto ^a   Maggioni, Aldo P ^a,b   Franzosi, MariaGrazia ^a   Santoro, Luigi ^a   Tognoni, Gianni ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b ANMCO RESEARCH CENTER   (Italy)

Author keywords

Diabetes mellitus; Lisinopril; Mortality; Myocardial infarction

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; LISINOPRIL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; FEMALE; HUMAN; HYPOTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0031439405     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.12.4239     Document Type: Article

References (23)

1. Smith JW, Marcus FI, Serokman R, for the Multicenter Postinfarction Research Group. Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol. 1984;54:718-721.
2. Singer DE, Moulton AW, Nathan DM. Diabetic myocardial infarction: interaction of diabetes with other preinfarction risk factors. Diabetes. 1989;38:350-357.
3. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, Turi ZG, Strauss W, Willerson JT, Robertson T, Braunwald E, Jaffe AS, and the MILIS Study Group. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol. 1989;14:49-57.
4. Savage MP, Krolewski AS, Kenien GG, Lebeis MP, Christlieb AR, Lewis SM. Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am J Cardiol. 1988;62:665-669.
5. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG, for the GISSI-2 Investigators. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol. 1993;22:1788-1794.
6. Lee KL, Woodlief LH, Topol EJ, Weaver D, Betriu A, Col J, Simoons M, Aylward P, Van de Werf F, Califf RM, for the GUSTO-I Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41 021 patients. Circulation. 1995;91:1659-1668.
7. Mueller HS, Cohen LS, Braunwald E, Forman S, Feit F, Ross A, Schweiger M, Cabin H, Davison R, Miller D, Solomon R, Knatterud GL, for the TIMI Investigators. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction: analyses of patient subgroups in the thrombolysis in myocardial infarction (TIMI) trial, phase II. Circulation. 1992;85:1254-1264.
8. Laffer LMB, McGill JB, Gans DJ, on behalf of the North American Micro Albuminuria Study Group. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. Am J Med. 1995;99:497-504.
9. Latini R, Maggioni AP, Flather M, Sleight P, Tognoni G. ACE-inhibitor use in patients with myocardial infarction: summary of evidence from clinical trials. Circulation. 1995;92:3132-3137.
10. Schwartz PJ, Priori SG. Sympathetic nervous system and cardiac arrhythmias. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders Co; 1990:330-343.
11. Neri V, Parravicini I, Monza G, Petessio A, Roda L. Osservazioni sul comportamento dell'attività reninica plasmatica nell'infarto miocardico acuto. G Ital Cardiol. 1982;12:324-326.
12. Woodfield SL, Lundergan CF, Reiner JS, Greenhouse SW, Thompson MA, Rorhbeck SC, Deychak Y, Simoons ML, Califf RM, Topol EJ, Ross A, for the GUSTO-I Angiographic Investigators. Angiographic findings and outcome in diabetics treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol. 1996;28:1661-1669.
13. Navis G, Faber HJ, de Zeeuw D, de Jong FE. ACE inhibitors and the kidney: a risk-benefit assessment. Drug Safety. 1996;15:200-211.
14. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico, GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;343:1115-1122.
15. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335-371.
16. Jacoby RM, Nesto RW. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol. 1992;20:736-744.
17. Zuanetti G, Latini R. Impact of pharmacological treatment on mortality after myocardial infarction in diabetic patients. J Diabetes Complications. 1997;11:131-136.
18. Moyé LA, Pfeffer MA, Wun CC, Davis BR, Geltman E, Hayes D, Farnham DJ, Randall OS, Dinh H, Arnold JMO, Kupersmith J, Hager D, Classer SP, Biddle T, Hawkins CM, Braunwaid E, for the SAVE Investigators. Uniformity of captopril benefit in the SAVE study: subgroup analysis. Eur Heart J. 1994;15:2-8.
19. Torp-Pedersen C, Kober L, Carlsen J, on behalf of the TRACE Study Group, Angiotensin-converting enzyme inhibition after myocardial infarction: the Trandolapril Cardiac Evaluation study. Am Heart J. 1996;132:235-243.
20. GISSI-3: Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3 study protocol on the effects of lisinopril, of nitrates, and of their association in patients with acute myocardial infarction. Am J Cardiol. 1992;70:62C-69C.
21. Malmberg K, Rydén L, Efendic S, Herlitz J, Nicol P, Waldenström A, Wedel H, Welin L, on behalf of the DIGAMI Study Group. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
22. Swedberg K, Held P, Kjekshus J, Rasmussen K, Rydén L, Wedel H, CONSENSUS II Study Group. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. N Engl J Med. 1992;327:678-684.
23. ACC/AHA Guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1996;28:1328-1428.